BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND ATRX, P46100, ZNF-HX, XNP, XH2, SHS, SFM1, RAD54, MRXHF1, MGC2094, ATR2, 546 AND Prognosis
140 results:

  • 1. A multi-omics analysis-based model to predict the prognosis of low-grade gliomas.
    Du Z; Jiang Y; Yang Y; Kang X; Yan J; Liu B; Yang M
    Sci Rep; 2024 Apr; 14(1):9427. PubMed ID: 38658591
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. High-Grade Astrocytoma with Piloid Features: A Dual Institutional Review of Imaging Findings of a Novel Entity.
    Soni N; Agarwal A; Ajmera P; Mehta P; Gupta V; Vibhute M; Gubbiotti M; Mark IT; Messina SA; Mohan S; Bathla G
    AJNR Am J Neuroradiol; 2024 Apr; 45(4):468-474. PubMed ID: 38485198
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Intracranial dural arteriovenous fistulas: association with cerebral venous thrombosis, baseline aggressiveness, and clinical outcomes. A retrospective multicenter study on 263 consecutive patients and literature review.
    Cohen C; Lenck S; Talbi A; Ifergan H; Premat K; Boulouis G; Janot K; Boch AL; Magni C; Herbreteau D; Sourour N; Shotar E; Barrot V; Clarençon F
    Neurosurg Focus; 2024 Mar; 56(3):E9. PubMed ID: 38428003
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. IDH1 mutation predicts seizure occurrence and prognosis in lower-grade glioma adults.
    Tang T; Wang Y; Dai Y; Liu Q; Fan X; Cheng Y; Tang J; Xiao X; Shan Y; Wei P; Zhao G
    Pathol Res Pract; 2024 Feb; 254():155165. PubMed ID: 38286053
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. General Clinico-Pathological Characteristics in Glioblastomas in Correlation with p53 and Ki67.
    Sipos TC; Kövecsi A; Ovidiu-Ioan Ș; Zsuzsánna P
    Medicina (Kaunas); 2023 Oct; 59(11):. PubMed ID: 38003967
    [No Abstract]    [Full Text] [Related]  

  • 6. An immune signature to predict the prognosis of
    Cao W; Sun P; Luo S; Zeng Z; Xiao C; Yu W; Lei S
    Aging (Albany NY); 2023 Oct; 15(19):10453-10472. PubMed ID: 37812190
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Predictive IDH Genotyping Based on the Evaluation of Spatial Metabolic Heterogeneity by Compartmental Uptake Characteristics in Preoperative Glioma Using
    Lohmeier J; Radbruch H; Brenner W; Hamm B; Tietze A; Makowski MR
    J Nucl Med; 2023 Nov; 64(11):1683-1689. PubMed ID: 37652542
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. A threshold for mitotic activity and post-surgical residual volume defines distinct prognostic groups for astrocytoma IDH-mutant.
    Tran S; Thomas A; Aliouat I; Karachi C; Lozano F; Mokhtari K; Dehais C; Feuvret L; Carpentier C; Giry M; Doukani A; Lerond J; Marie Y; Sanson M; Idbaih A; Carpentier A; Hoang-Xuan K; Touat M; Capelle L; Bielle F
    Neuropathol Appl Neurobiol; 2023 Aug; 49(4):e12928. PubMed ID: 37503540
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Diagnostic algorithm for pathological evaluation of gliomas in a resource-constrained setting.
    Jain S; Gupta P; Shankar KB; Singh R; Siraj F
    J Cancer Res Ther; 2023; 19(3):562-566. PubMed ID: 37470575
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Differences in survival prognosticators between children and adults with H3K27M-mutant diffuse midline glioma.
    Gong X; Kuang S; Deng D; Wu J; Zhang L; Liu C
    CNS Neurosci Ther; 2023 Dec; 29(12):3863-3875. PubMed ID: 37311690
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Practice of IDH1, atrx, and P53 Immunohistochemistry in Integrated Diagnosis of Adult Diffuse Gliomas: Single Center Study.
    Shabanzadeh Nejabad Z; Mabroukzadeh Kavari H; Saffar H; Tavangar SM; Sefidbakht S; Khoshnevisan A; Zare-Mirzaie A; Vasei M; Jafari E; Yaghmaii M; Saffar H
    Appl Immunohistochem Mol Morphol; 2023 Jul; 31(6):390-398. PubMed ID: 37278280
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Multimodal-based machine learning strategy for accurate and non-invasive prediction of intramedullary glioma grade and mutation status of molecular markers: a retrospective study.
    Ma C; Wang L; Song D; Gao C; Jing L; Lu Y; Liu D; Man W; Yang K; Meng Z; Zhang H; Xue P; Zhang Y; Guo F; Wang G
    BMC Med; 2023 May; 21(1):198. PubMed ID: 37248527
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Genomic profiles of IDH-mutant gliomas: MYCN-amplified IDH-mutant astrocytoma had the worst prognosis.
    Lee K; Kim SI; Kim EE; Shim YM; Won JK; Park CK; Choi SH; Yun H; Lee H; Park SH
    Sci Rep; 2023 Apr; 13(1):6761. PubMed ID: 37185778
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Prediction of Ki-67 labeling index, atrx mutation, and MGMT promoter methylation status in IDH-mutant astrocytoma by morphological MRI, SWI, DWI, and DSC-PWI.
    Yang X; Hu C; Xing Z; Lin Y; Su Y; Wang X; Cao D
    Eur Radiol; 2023 Oct; 33(10):7003-7014. PubMed ID: 37133522
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Overexpression of Podoplanin Predicts Poor prognosis in Patients With Glioma.
    He J; Zhang G; Yuan Q; Wang S; Liu Z; Wang M; Cai H; Wan J; Zhao B
    Appl Immunohistochem Mol Morphol; 2023 May-Jun 01; 31(5):295-303. PubMed ID: 37093708
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Diffuse midline glioma with H3K27 alteration in adults: a clinicopathological analysis].
    Yang QY; Li MN; Chen TY; Liu C; Li X; Shi ZM; Pan MH
    Zhonghua Bing Li Xue Za Zhi; 2023 Apr; 52(4):376-383. PubMed ID: 36973199
    [No Abstract]    [Full Text] [Related]  

  • 17. Clinical, histopathological and molecular risk factors for recurrence of pilocytic astrocytomas: brainstem/spinal location, nestin expression and gain of 7q and 19 are associated with early tumor recurrence.
    Tamura R; Iwanami A; Ohara K; Nishimoto M; Pareira ES; Miwa T; Tsuzaki N; Kuranari Y; Morimoto Y; Toda M; Okano H; Nakamura M; Yoshida K; Sasaki H
    Brain Tumor Pathol; 2023 Apr; 40(2):109-123. PubMed ID: 36892668
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Genomic profiling and prognostic factors of H3 K27M-mutant spinal cord diffuse glioma.
    Chai RC; Yan H; An SY; Pang B; Chen HY; Mu QH; Zhang KN; Zhang YW; Liu YQ; Liu X; Zhao Z; Jiang T; Wang YZ; Jia WQ
    Brain Pathol; 2023 Jul; 33(4):e13153. PubMed ID: 36751054
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. IDH-mutant diffuse gliomas: tips and tricks in the era of genomic tumor classification.
    Ammendola S; Broggi G; Barresi V
    Histol Histopathol; 2023 Jul; 38(7):739-753. PubMed ID: 36651583
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The prognostic significance of tumor-associated neutrophils and circulating neutrophils in glioblastoma (WHO CNS5 classification).
    Wang X; Li X; Wu Y; Hong J; Zhang M
    BMC Cancer; 2023 Jan; 23(1):20. PubMed ID: 36609243
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 7.